Halbert Hargrove Global Advisors, LLC Merck & Co., Inc. Transaction History

Halbert Hargrove Global Advisors, LLC

$1.81 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$102.94 - $114.86 $80,602 - $89,935	783 Added 16.15%	5,632 $599,000
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $31,740 - $40,695	363 Added 8.09%	4,849 $0
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $43,871 - $49,284	519 Added 13.08%	4,486 $386,000
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $11,939 - $13,533	-143 Reduced 3.48%	3,967 $362,000
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $8,012 - $8,981	109 Added 2.72%	4,110 $337,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $12,070 - $15,120	167 Added 4.36%	4,001 $307,000
Q3 2021 Oct 29, 2021	SELL	$71.68 - $78.83 $16,773 - $18,446	-234 Reduced 5.75%	3,834 $288,000
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $7,452 - $8,243	106 Added 2.68%	4,068 $316,000
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $2,203 - $2,595	-32 Reduced 0.8%	3,962 $306,000
Q4 2020 Feb 04, 2021	SELL	$71.77 - $79.65 $5,310 - $5,894	-74 Reduced 1.82%	3,994 $326,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $16,099 - $18,249	220 Added 5.72%	4,068 $338,000
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $9,154 - $10,416	-130 Reduced 3.27%	3,848 $298,000
Q1 2020 May 01, 2020	BUY	$63.36 - $87.82 $6,652 - $9,221	105 Added 2.71%	3,978 $306,000
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $33,902 - $38,254	-437 Reduced 10.14%	3,873 $352,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $13,237 - $14,429	174 Added 4.21%	4,310 $363,000
Q2 2019 Jul 26, 2019	SELL	$69.84 - $81.59 $698 - $815	-10 Reduced 0.24%	4,136 $347,000
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $12,106 - $13,808	-174 Reduced 4.03%	4,146 $345,000
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $1,370 - $1,589	21 Added 0.49%	4,320 $330,000
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $9,172 - $10,786	-159 Reduced 3.57%	4,299 $305,000
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $10,877 - $12,780	214 Added 5.04%	4,458 $271,000
Q1 2018 May 01, 2018	SELL	$50.96 - $59.23 $9,325 - $10,839	-183 Reduced 4.13%	4,244 $231,000
Q4 2017 Feb 01, 2018	SELL	$51.62 - $61.64 $26,274 - $31,374	-509 Reduced 10.31%	4,427 $249,000
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $289,595 - $311,609	4,936	4,936 $316,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account